Efforts have been made expecting to prove the clinical significance of circulating IGF-1 and IGFBP-3 in cancers by evidence-based methods [37], [38], [39], [40], [41], [42], among which lung cancer is a magnificent being [43], [44]. This evidence concerns the gene IGF1 and lung carcinoma.